Select Page

Tag: FDA

Cigar News: Federal Judge Delays Cigar Warning Requirements

Earlier today, D.C. District Court Judge Amit Mehta issued an injunction prohibiting the U.S. Food & Drug Administration from enforcing its warning label requirements on cigars and pipe tobacco. The warning label requirements for packaging and advertising were slated to go into effect on August 10th. Judge Mehta’s order delays any enforcement of the requirement until at least 60 days after the conclusion of an appeal currently underway. No date has been set for a court to hear the appeal.

Read More

Cigar News: FDA Will Re-Evaluate Premium Cigar Regulation

The FDA is taking another look at premium cigars in a move that anti-tobacco groups fear could weaken regulations. It’s the latest push under Commissioner Scott Gottlieb to undertake a sweeping overall of tobacco and nicotine regulation. The FDA recently took the first step in lowering the amount of nicotine in cigarettes. It also said it’s seeking information on the role flavors, including menthol, play in attracting people to tobacco products and alternatives like e-cigarettes.

Read More

Cigar News: House Bill Passes with Premium Cigar Exemption

Earlier today the US House of Representatives passed a 12 bill spending package that includes a provision prohibiting the FDA from enforcing regulations against premium cigars. The bill, known as an omnibus appropriations package, passed the House by 211-198 votes and will now move to the Senate for consideration. Congress has until December 8th to pass spending legislation and fund the federal government.

Read More

Cigar News: FDA, IPCPR & CRA Announce New Plan for Premium Tobacco

FOR IMMEDIATE RELEASE – July 28, 2017 – WASHINGTON, D.C. – Today, Commissioner of the U.S. Food & Drug Administration, Dr. Scott Gottlieb, announced a new comprehensive plan for the approach the agency will take to the regulation of tobacco products, placing an emphasis on a science-based method, that notes a “continuum of risk” that recognizes the differences in tobacco products.

Read More

Cigar News: Senate Confirms Dr. Scott Gottlieb as FDA Commissioner

Earlier today the United States Senate confirmed Dr. Scott Gottlieb as the next Commissioner of the Food & Drug Administration (FDA). IPCPR applauds the Senate’s decision to put thoughtful and experienced leadership at the head of an organization as critical as the FDA. Dr. Gottlieb’s confirmation puts a reform minded physician with experience in both the public and private sectors in charge of a regulatory body that has too often failed in its mission to protect the public health without needlessly hampering commerce in this country. The small business retailers and professional tobacconists that make up IPCPR are counting on the leadership of Dr. Gottlieb and the actions of his FDA to address and correct the onerous and catastrophic elements of last year’s Deeming Rule.

Read More

Cigar News: Famous Smoke Launches Cigar Smokers’ Rights Guide

EASTON, PA–(Marketwired – March 30, 2017) – Famous Smoke Shop, the leading online distributor of discounted premium cigars, has debuted their new interactive Cigar Smokers’ Rights Hub. Crafted in response to the US Food & Drug Administration’s 2016 Final Deeming Rule regarding premium cigars and other tobacco products, the Famous Smoke guide presents cigar enthusiasts with a history of legal actions affecting the tobacco industry. The Smokers’ Rights Hub also offers cigar smokers a detailed understanding of how FDA’s new regulations will negatively impact the premium cigar industry, and the legal challenges that have been mounted against the agency’s sweeping new rules.

Read More

Cigar News: Allied Associations’ Federal Lawsuit Delayed One Month

The lawsuit filed jointly by IPCPR, CRA and CAA against the FDA will now be heard on August 30th, pushing the trial back from July 28th. The change was in response to the FDA’s original motion for a 60 day delay, in part to accommodate the transition from the Obama to Trump Administrations. The three trade associations agreed to the 30 day extension, however all three have made it clear to the federal government that any further delays would require extensions of pending compliance deadlines under the deeming rule.

Read More

Cigar News: Dr. Scott Gottlieb Nominated as next FDA Commissioner

Today President Trump announced Dr. Scott Gottlieb as his pick to lead the Food & Drug Administration (FDA). Dr. Gottlieb has an impressive and extensive resume, with a wide-ranging background in both the private and public sectors and a M.D. from Mount Sinai School of Medicine. IPCPR welcomes the pick of Dr. Gottlieb and, If confirmed, we look forward to working with him as we continue to advocate for common-sense reforms to the recent FDA regulation needlessly harming the family owned small businesses retailers that make up IPCPR.

Read More

Cigar News: Congressman Testifies before House Subcommittee for Cigar Exemption

Yesterday Congressman Bill Posey (R-FL) testified before the House Appropriations Subcommittee on Agriculture about the need for appropriations language exempting premium cigars from the FDA’s deeming rule. This testimony came during the Appropriations Committee’s annual members’ day. IPCPR applauds Congressman Posey and extends our thanks on behalf of premium cigar retailers and tobacconists across the country for his continued fight for premium cigars and individual liberty.

Read More

Cigar News: Congressmen Send Letter to Vice President Pence on Regulation of Premium Cigars

Congressmen Send Letter to Vice President Pence on Regulation of Premium Cigars

On behalf of the premium cigar industry as well as main street retailers and American consumers, Congressman Bill Posey (R-Florida), Congressman Duncan Hunter (R-California) and Congressman Lou Barletta (R-Pennsylvania) sent a letter to Vice President Pence urging the new administration to swiftly suspend enforcement of the FDA’s recently enacted deeming rule. The rule, which went into effect on August 8, 2016 has imposed harsh new regulations on premium cigar retailers, manufacturers and thousands of small businesses across the country. Despite the original congressional intent, the FDA’s imposition of regulations on premium cigars penalizes an industry where youth access to smoking is a non-issue.

Read More